Global molecular epidemiology of carbapenem-resistant Escherichia coli (2002–2017)
Authors:
- 19 July 2021
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- p. 1-13
Abstract
The emergence of carbapenem-resistant (CR) Escherichia coli obliges an assessment of such strains’ molecular epidemiology. Accordingly, we characterized in detail a globally distributed collection of CR E. coli isolates, then explored for associations between geographical origin and bacterial traits, and between different bacterial traits. We used established PCR-based assays and broth microdilution MIC determinations to characterize 343 global CR (i.e., non-susceptible to ≥ 1 carbapenem) extraintestinal E. coli isolates (2002–2017) for diverse molecular traits—including phylogroups, sequence types (STs), beta-lactamase genes, and 51 virulence genes—and susceptibility to 12 relevant antimicrobial agents. The study population was tremendously diverse according to all assessed variables. Nonetheless, certain geographically aligned, unifying themes emerged. These included an association of an Asia/West Pacific origin with non-B2/D/F phylogroups and STs, lower molecularly inferred virulence, more extensive resistance, and specific resistance genes (notably, metallo-beta-lactamases). Likewise, U.S. isolates from the central region, vs. other regions, were more virulent-appearing and more often from phylogroup B2 and ST131, but less extensively resistant and more often carbapenemase-gene negative. The global CR E. coli population is highly diverse according to multiple characteristics and varies significantly by geographical region. This predictably will pose challenges for prevention and management, and obliges ongoing surveillance.Keywords
Funding Information
- Cipla
- Allergan
- Merck
- Melinta
- Shionogi
- Tetraphase
- Biomedical Laboratory Research and Development, VA Office of Research and Development
This publication has 39 references indexed in Scilit:
- Association of Fluoroquinolone Resistance, Virulence Genes, and IncF Plasmids with Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 (ST131) and ST405 Clonal GroupsAntimicrobial Agents and Chemotherapy, 2013
- Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US VeteransClinical Infectious Diseases, 2013
- The C lermont
E
scherichia coli
phylo‐typing method revisited: improvement of specificity and detection of new phylo‐groupsEnvironmental Microbiology Reports, 2012
- Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemasesJournal of Antimicrobial Chemotherapy, 2011
- Distribution of Human Commensal Escherichia coli Phylogenetic GroupsJournal of Clinical Microbiology, 2010
- The population genetics of commensal Escherichia coliNature Reviews Microbiology, 2010
- Characteristics of human intestinal Escherichia coli with changing environmentsEnvironmental Microbiology, 2008
- Chi‐squared and Fisher–Irwin tests of two‐by‐two tables with small sample recommendationsStatistics in Medicine, 2007
- Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problemMicrobes and Infection, 2003
- Are Quinolone‐Resistant UropathogenicEscherichia coliLess Virulent?The Journal of Infectious Diseases, 2002